{"meta":{"query_hash":"5b4edef27fa5","filters":{"venue":"European Neurological Review"},"cohort_total":19,"direct_labels_cover":0,"predictions_cover":19,"exported":19,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5b4edef27fa5","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Neurological+Review"},"results":[{"id":"W2183127476","doi":"10.17925/enr.2012.07.01.28","title":"Deep Brain Stimulation for Parkinson’s Disease - A Review","year":2012,"lang":"en","type":"review","venue":"European Neurological Review","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders; University of British Columbia","funders":"","keywords":"Deep brain stimulation; Dyskinesia; Medicine; Parkinson's disease; Intervention (counseling); Motor symptoms; Disease; Refractory (planetary science); Medical therapy; Physical medicine and rehabilitation; Intensive care medicine; Physical therapy; Psychiatry; Surgery; Internal medicine","score_opus":0.12698532006275248,"score_gpt":0.37837185007707724,"score_spread":0.25138653001432476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183127476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.3055556e-7,0.98196036,0.00010558896,0.0052125696,0.00018974516,0.010416025,0.000072841445,0.00022816019,0.0018142571],"genre_scores_gemma":[0.0000031776517,0.8971343,0.0001773682,0.099844545,0.00033243446,0.0008401084,0.001034415,0.0001682659,0.00046536885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937274,0.0022052939,0.0015665034,0.0012803096,0.0004410966,0.0007794295],"domain_scores_gemma":[0.99612063,0.0009353439,0.0007677706,0.0011402587,0.00008767603,0.00094831997],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001153159,0.001017023,0.0041903392,0.000082383754,0.00013145343,0.000026241301,0.00044712215,0.00016123659,0.0007865662],"category_scores_gemma":[0.0033749507,0.0005916863,0.0025316917,0.00045664457,0.000103453465,0.0000734845,0.00024449782,0.00075313257,0.0015569201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038587434,0.0003884638,0.000025346208,0.25177243,0.00007550621,0.0004242538,4.2312377e-7,5.1067772e-8,8.22625e-9,0.000048863225,0.016880918,0.73034513],"study_design_scores_gemma":[0.00045383768,0.00081966916,0.00047022945,0.10559523,0.011386261,0.00007807367,2.5446793e-8,0.000005843825,1.0474184e-9,0.00006133293,0.8807226,0.0004068975],"about_ca_topic_score_codex":1.8746435e-7,"about_ca_topic_score_gemma":1.1188392e-7,"teacher_disagreement_score":0.86384165,"about_ca_system_score_codex":0.0000355513,"about_ca_system_score_gemma":0.00007955382,"threshold_uncertainty_score":0.99965346},"labels":[],"label_agreement":null},{"id":"W2398521763","doi":"10.17925/enr.2013.08.02.130","title":"Symptomatic Treatment in Multiple Sclerosis","year":2013,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Multiple sclerosis; Spasticity; Depression (economics); Quality of life (healthcare); Disease; Physical medicine and rehabilitation; Gait; Physical therapy; Balance (ability); Activities of daily living; Psychiatry; Internal medicine","score_opus":0.17292346520806973,"score_gpt":0.3231499066670848,"score_spread":0.1502264414590151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398521763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9146865,0.04265928,0.000008247403,0.016999481,0.00006352104,0.004393545,0.0000046695086,0.00023917205,0.020945609],"genre_scores_gemma":[0.7929614,0.19826561,0.00036623474,0.0076346877,0.000068483816,0.0003037323,0.000008336225,0.000032401196,0.00035911376],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99740976,0.00083157595,0.00052585907,0.00045818486,0.00030981877,0.000464793],"domain_scores_gemma":[0.9986739,0.00042711824,0.000076224525,0.0004929028,0.000067969704,0.0002618813],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00044148613,0.0002493297,0.00067612575,0.00007496589,0.00006332348,0.000025370204,0.00017953149,0.000028171355,0.0010177104],"category_scores_gemma":[0.0027220044,0.00014633263,0.00020145244,0.0003206153,0.000125896,0.00006825577,0.00017590335,0.00024336798,0.004418636],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061655956,0.0014190195,0.18278755,0.0022257278,0.000080340345,0.00045943054,0.0000789183,0.0000039042993,0.005133055,0.000022528375,0.016219353,0.7915085],"study_design_scores_gemma":[0.0012395753,0.001040733,0.95551157,0.0018144016,0.000038014474,0.000020371368,0.0000030701997,0.0003297243,0.000025170746,0.00000553712,0.039844003,0.00012785733],"about_ca_topic_score_codex":0.000034393062,"about_ca_topic_score_gemma":0.00000489041,"teacher_disagreement_score":0.79138064,"about_ca_system_score_codex":0.000051352155,"about_ca_system_score_gemma":0.000016935612,"threshold_uncertainty_score":0.9998955},"labels":[],"label_agreement":null},{"id":"W2476064101","doi":"10.17925/enr.2009.04.02.29","title":"The Effect of Non-motor Symptoms on Quality of Life in Parkinson's Disease","year":2009,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of New Brunswick","funders":"","keywords":"Medicine; Parkinson's disease; Motor symptoms; Quality of life (healthcare); Disease; Affect (linguistics); Pediatrics; Physical medicine and rehabilitation; Physical therapy; Psychiatry; Internal medicine; Psychology","score_opus":0.025012203799490835,"score_gpt":0.31378410860621886,"score_spread":0.28877190480672804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476064101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95994484,0.03430553,0.0000043125724,0.0017399454,0.000052468833,0.0010947313,0.000017099326,0.000026571075,0.00281452],"genre_scores_gemma":[0.97403586,0.021172287,0.000011223748,0.0046631987,0.000035259673,0.000017572227,0.0000072615735,0.0000133556005,0.000043962],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996948,0.0015306764,0.00060272944,0.00034457757,0.0003453614,0.00022865417],"domain_scores_gemma":[0.99833995,0.00048453404,0.0002657211,0.00056373054,0.000029576062,0.00031650657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012162289,0.00021344323,0.0007413228,0.000035792687,0.000037780046,0.0000053700414,0.00020637421,0.00002432289,0.000034367462],"category_scores_gemma":[0.0023846691,0.000105689076,0.0003327745,0.00019219267,0.00007572195,0.000018948876,0.0000464035,0.00018910381,0.00006434449],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014245452,0.002791832,0.4484591,0.0051785805,0.00015778287,0.002030664,0.000013042693,0.000007792144,0.001022213,0.0010373268,0.0015186734,0.5235376],"study_design_scores_gemma":[0.0014846516,0.0055913804,0.95450515,0.0011070758,0.00013351406,0.0000018105804,1.6737235e-7,0.000018953775,0.0000326677,0.000029483319,0.037018172,0.00007700557],"about_ca_topic_score_codex":0.0000015808207,"about_ca_topic_score_gemma":1.8430286e-7,"teacher_disagreement_score":0.52346057,"about_ca_system_score_codex":0.000010531708,"about_ca_system_score_gemma":0.000025335794,"threshold_uncertainty_score":0.43098754},"labels":[],"label_agreement":null},{"id":"W2479037164","doi":"10.17925/enr.2011.06.03.161","title":"Advances in the Role of Neuroimaging to Monitor Disease Progression in Parkinson’s Disease","year":2011,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche sur Alzheimer; Michael Smith Health Research BC; Teva Pharmaceutical Industries","keywords":"Positron emission tomography; Neuroimaging; Medicine; Parkinson's disease; Neuroscience; Functional imaging; Dopaminergic; Putamen; Biomarker; Disease; Functional neuroimaging; Emission computed tomography; Imaging biomarker; Cerebral blood flow; Pet imaging; Dopamine; Pathology; Internal medicine; Magnetic resonance imaging; Psychology; Radiology; Biology","score_opus":0.035431052390475025,"score_gpt":0.3108085070481553,"score_spread":0.2753774546576803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479037164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.697437,0.28818333,0.00001155399,0.002294552,0.00009173316,0.0024901396,0.00002123858,0.000067368834,0.009403083],"genre_scores_gemma":[0.94847625,0.046036746,0.00016943082,0.0051371395,0.000035167806,0.00010863491,0.0000073584774,0.00002187457,0.000007392737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774176,0.00080920913,0.00039489375,0.00046083878,0.0003078142,0.0002854919],"domain_scores_gemma":[0.9989352,0.00005708089,0.00010792392,0.00046460575,0.000026086347,0.00040906115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042007375,0.00020531334,0.00035304888,0.00007987524,0.000030916795,0.000007913508,0.00027659052,0.000011596262,0.000061467304],"category_scores_gemma":[0.0005367783,0.0001148154,0.00013732877,0.0003442257,0.000048522437,0.00008691572,0.00011828017,0.0001936876,0.00008210372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011308151,0.0017704774,0.5269652,0.0007718195,0.0000044433514,0.0073211286,0.00008181681,0.0000018562904,0.000048895505,0.00022956822,0.000057028512,0.46161693],"study_design_scores_gemma":[0.00040181723,0.00035853483,0.84054434,0.0016553623,0.00008577798,0.000007216812,0.0000052409155,0.000033658882,0.000009027931,0.00028534024,0.15652393,0.000089758665],"about_ca_topic_score_codex":0.0000022015774,"about_ca_topic_score_gemma":6.475481e-7,"teacher_disagreement_score":0.46152717,"about_ca_system_score_codex":0.000009817115,"about_ca_system_score_gemma":0.000020826601,"threshold_uncertainty_score":0.4682036},"labels":[],"label_agreement":null},{"id":"W2480287584","doi":"10.17925/enr.2009.04.01.36","title":"Population-based Studies on the Clinical Progression of Motor and Non-motor Features in Parkinson’s Disease","year":2009,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Population; Apathy; Dementia; Parkinson's disease; Disease; Movement disorders; Physical medicine and rehabilitation; Depression (economics); Cognition; Psychiatry; Internal medicine","score_opus":0.06602022239602924,"score_gpt":0.3802117149898312,"score_spread":0.31419149259380197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480287584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93642616,0.052381627,0.000001184187,0.009494936,0.000068177476,0.0013185334,0.000012563971,0.00003223024,0.0002646066],"genre_scores_gemma":[0.95793587,0.025077295,0.00012879669,0.016717067,0.000059394497,0.000027232158,0.000011310091,0.000011776567,0.000031273645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790716,0.00080956606,0.0004834172,0.000393037,0.0002466106,0.00016019223],"domain_scores_gemma":[0.99888295,0.00034746825,0.00018976118,0.00033434806,0.00003819194,0.00020728716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074273406,0.00018923779,0.00052418676,0.000039264898,0.00005389042,0.000007864889,0.00010228139,0.000028032013,0.00001829826],"category_scores_gemma":[0.002049491,0.000090043104,0.00018007183,0.00012020631,0.000066914756,0.000019001245,0.000040174877,0.00022340626,0.000015833995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040750904,0.0039695767,0.70844144,0.0017835042,0.00009604867,0.0034792586,0.000022146052,0.000004568875,0.00010587801,0.00066872523,0.0022814395,0.27507234],"study_design_scores_gemma":[0.0007503389,0.0024801733,0.98471177,0.0023434132,0.0001487603,0.0000030564413,9.872389e-7,0.00004757208,0.0000041072153,0.00011465558,0.009322403,0.000072743125],"about_ca_topic_score_codex":5.724299e-7,"about_ca_topic_score_gemma":3.1852835e-7,"teacher_disagreement_score":0.27627036,"about_ca_system_score_codex":0.0000100353045,"about_ca_system_score_gemma":0.000021732669,"threshold_uncertainty_score":0.36718515},"labels":[],"label_agreement":null},{"id":"W2481203324","doi":"10.17925/enr.2008.03.02.64","title":"Repetitive Transcranial Magnetic Stimulation as a Complementary Treatment for Post-stroke Aphasia","year":2008,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Spatial Neglect and Hemispheric Dysfunction","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Transcranial magnetic stimulation; Medicine; Aphasia; Stroke (engine); Physical medicine and rehabilitation; Stimulation; Psychiatry; Internal medicine; Engineering","score_opus":0.0710531394806821,"score_gpt":0.3013187105866479,"score_spread":0.2302655711059658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481203324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92606515,0.010716221,0.0027915053,0.007626271,0.0008069643,0.006771465,0.00028382568,0.0006993345,0.044239275],"genre_scores_gemma":[0.93181103,0.03129201,0.00049654936,0.033730473,0.00035714344,0.00013361123,0.00007067302,0.000059572063,0.0020489413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978207,0.00057772663,0.00042051007,0.00062054966,0.0002447443,0.00031578494],"domain_scores_gemma":[0.9990862,0.00035613254,0.00012042119,0.0002515056,0.000053027517,0.00013272568],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001385261,0.00025023575,0.00034306262,0.000027031077,0.0002790344,0.000018119556,0.00019545922,0.000028246684,0.0015035359],"category_scores_gemma":[0.000597281,0.00018627584,0.00027307184,0.00015695862,0.000115583294,0.00008240628,0.00003129351,0.00012185958,0.00038820656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029988086,0.0017246153,0.0010338173,0.0005509452,0.000027354534,0.002899136,0.00037016795,0.000055296718,0.44516316,0.00082423695,0.0041853352,0.5401671],"study_design_scores_gemma":[0.006747738,0.039512273,0.025431192,0.0003621182,0.00043796215,0.0017627358,0.000006884147,0.0015686273,0.0062940447,0.00019670857,0.91678053,0.0008992105],"about_ca_topic_score_codex":0.00001336764,"about_ca_topic_score_gemma":0.0000025808067,"teacher_disagreement_score":0.91259515,"about_ca_system_score_codex":0.000024009067,"about_ca_system_score_gemma":0.000025976537,"threshold_uncertainty_score":0.9994092},"labels":[],"label_agreement":null},{"id":"W2482400956","doi":"10.17925/enr.2009.04.01.72","title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy - An Overview of Intravenous Immunoglobulin Therapy","year":2009,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Polyradiculoneuropathy; Placebo; Regimen; Intravenous Immunoglobulins; Maintenance therapy; Internal medicine; Antibody; Pediatrics; Immunology; Chemotherapy; Guillain-Barre syndrome; Pathology; Alternative medicine","score_opus":0.05286088149785559,"score_gpt":0.315881552259179,"score_spread":0.2630206707613234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482400956","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49098706,0.50093526,0.000017789136,0.0029863832,0.00010658598,0.00075581257,0.0000038467792,0.00020386827,0.0040033595],"genre_scores_gemma":[0.54853946,0.42335346,0.00007580857,0.02775096,0.00019407424,0.0000041101216,0.00001129553,0.000037167592,0.00003368519],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966561,0.0011208568,0.0008577392,0.00053659716,0.00035797677,0.00047072198],"domain_scores_gemma":[0.9985984,0.00005978107,0.00031361062,0.0006908676,0.000091924325,0.0002454349],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007917118,0.00034641847,0.00078063464,0.000054895398,0.00009106071,0.000016934418,0.00037985694,0.000055147546,0.0002828837],"category_scores_gemma":[0.00043351867,0.00024663648,0.00032294547,0.00034169445,0.00013964184,0.000110132416,0.000077145225,0.0005623453,0.00007716185],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023760584,0.0005592884,0.00074964704,0.0011281695,0.0000201128,0.0013578001,0.000052831907,0.000012673202,0.01310743,0.00079776737,0.0005762876,0.9814004],"study_design_scores_gemma":[0.0032025897,0.02852042,0.50742435,0.0036213023,0.00019630555,0.0010457004,0.000009616874,0.00019290319,0.00019312766,0.00028888858,0.45456758,0.0007371892],"about_ca_topic_score_codex":0.0000023490725,"about_ca_topic_score_gemma":6.281586e-7,"teacher_disagreement_score":0.9806632,"about_ca_system_score_codex":0.000018225115,"about_ca_system_score_gemma":0.00006990655,"threshold_uncertainty_score":0.99999857},"labels":[],"label_agreement":null},{"id":"W2485697989","doi":"10.17925/enr.2012.07.01.10","title":"Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis - A Medical, Sociological and Media Controversy","year":2012,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Medicine; Clinical trial; Skepticism; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.08131214355570238,"score_gpt":0.28661248805058737,"score_spread":0.205300344494885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485697989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8150301,0.17212029,0.000021202739,0.0067994655,0.00021278052,0.00092671084,0.0000090207495,0.0001731693,0.004707234],"genre_scores_gemma":[0.86714655,0.11797351,0.00014256207,0.014101548,0.0005483168,0.000021867369,0.000015059045,0.000037208345,0.000013362371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961679,0.0010390765,0.00073005265,0.0005831537,0.0005920609,0.0008877511],"domain_scores_gemma":[0.9979625,0.0006730014,0.00016495463,0.00039366566,0.000046146957,0.0007597341],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019351717,0.00034493717,0.001065341,0.000072493865,0.00012547361,0.000017225682,0.00029596247,0.00016767162,0.0015946138],"category_scores_gemma":[0.007104722,0.00023568794,0.00020402342,0.00028679322,0.0005903508,0.000106788546,0.00036823997,0.0009983677,0.00068624015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006250845,0.01911002,0.5311659,0.0062554395,0.00016846623,0.0025503945,0.00096829905,0.0000025388672,0.003655738,0.0027853835,0.012887585,0.41982517],"study_design_scores_gemma":[0.0019405719,0.0046825055,0.95673555,0.0017872566,0.00013625987,0.0004891172,0.000007267245,0.00006248996,0.0000066281286,0.000018361257,0.03385413,0.00027987454],"about_ca_topic_score_codex":0.000012981975,"about_ca_topic_score_gemma":0.000008352149,"teacher_disagreement_score":0.42556965,"about_ca_system_score_codex":0.00009371939,"about_ca_system_score_gemma":0.00008986038,"threshold_uncertainty_score":0.99931806},"labels":[],"label_agreement":null},{"id":"W2487755826","doi":"10.17925/enr.2011.06.03.181","title":"Primary Angiitis of the Central Nervous System - Clinical Approaches, Challenges and Controversies","year":2011,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Université de Montréal","keywords":"Medicine; Vasculitis; Headaches; Intensive care medicine; Central nervous system; Magnetic resonance imaging; Cerebral vasculitis; Pathology; Disease; Surgery; Radiology; Internal medicine","score_opus":0.15696103768357386,"score_gpt":0.25694419389438666,"score_spread":0.0999831562108128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487755826","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07765155,0.6804069,0.000011949522,0.008904399,0.000356359,0.0012260252,0.000017560254,0.00012752962,0.23129769],"genre_scores_gemma":[0.6614968,0.33444992,0.00008169546,0.0037620217,0.00008920019,0.0000047819467,0.0000046990745,0.000014689436,0.000096209886],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980247,0.000923395,0.0004588685,0.0002663485,0.00013909898,0.00018756482],"domain_scores_gemma":[0.999184,0.00013835306,0.00015955666,0.00034880027,0.00002957098,0.00013971642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053567276,0.00012334286,0.0005063113,0.000012316252,0.00004931767,0.00000308849,0.00014511142,0.000057400168,0.000040851333],"category_scores_gemma":[0.00036075385,0.00006247419,0.00030251965,0.000059641065,0.00027649326,0.000023940614,0.00013850581,0.00032772936,0.000022061759],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002428187,0.001102186,0.020055333,0.0147024235,0.0006166431,0.0021837607,0.0004425907,3.6890606e-7,0.000035272977,0.066012435,0.010229998,0.88437617],"study_design_scores_gemma":[0.00059281575,0.0005871819,0.94908226,0.0015501973,0.00045408384,0.0006570297,0.000017199276,0.0000052238875,0.0000011583373,0.000022084592,0.046959054,0.00007169035],"about_ca_topic_score_codex":0.0000012518957,"about_ca_topic_score_gemma":2.184167e-7,"teacher_disagreement_score":0.92902696,"about_ca_system_score_codex":0.0000054540783,"about_ca_system_score_gemma":0.000016244527,"threshold_uncertainty_score":0.25476232},"labels":[],"label_agreement":null},{"id":"W2493461058","doi":"10.17925/enr.2010.05.01.100","title":"nordic fMRI Solution - Products for Enhancing the Development of a Functional Imaging Clinical Practice","year":2010,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nordic Life Science Pipeline (Canada)","funders":"","keywords":"Medicine; Neurosurgery; Functional magnetic resonance imaging; Magnetic resonance imaging; Medical physics; Plan (archaeology); Clinical Practice; Radiology; Physical therapy","score_opus":0.08123079722976215,"score_gpt":0.3651654960492344,"score_spread":0.2839346988194722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493461058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6789208,0.06418026,0.0061701373,0.22847225,0.002484957,0.00719982,0.000007133364,0.00022915298,0.012335466],"genre_scores_gemma":[0.9647992,0.003940219,0.015686976,0.01483773,0.0005292026,0.000112543465,0.000023886107,0.000027469729,0.000042744698],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980881,0.00037188528,0.00075882586,0.00035773823,0.0002344536,0.00018898468],"domain_scores_gemma":[0.9981271,0.0008904239,0.00029554544,0.00033214307,0.00027384708,0.00008093821],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0032361697,0.00013377401,0.00032643668,0.00002066986,0.00013084224,0.000010771067,0.00010481542,0.000021490212,0.000046153695],"category_scores_gemma":[0.010159522,0.00007024011,0.0001643233,0.0001399318,0.00007581361,0.000051175895,0.00008887498,0.00033919752,0.00010237466],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047737235,0.0027899207,0.009521707,0.0018569675,0.0001853086,0.00023954472,0.00007544821,0.0000011670102,0.035081677,0.0009649543,0.025844213,0.9229617],"study_design_scores_gemma":[0.0007549597,0.00038572395,0.18627706,0.00041242142,0.00039719252,0.00026531235,0.0000035053863,0.000033979555,0.00066458137,0.000011654913,0.8107045,0.00008909794],"about_ca_topic_score_codex":3.7643127e-7,"about_ca_topic_score_gemma":0.000002200467,"teacher_disagreement_score":0.9228726,"about_ca_system_score_codex":0.0000069038792,"about_ca_system_score_gemma":0.00009735687,"threshold_uncertainty_score":0.9981783},"labels":[],"label_agreement":null},{"id":"W2493501087","doi":"10.17925/enr.2014.09.02.156","title":"Erratum to: Effect of Therapeutic Interventions on Health-related Quality of Life in Parkinson’s Disease","year":2015,"lang":"en","type":"erratum","venue":"European Neurological Review","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Parkinson's disease; Psychological intervention; Disease; Quality of life (healthcare); Intensive care medicine; Gerontology; Physical medicine and rehabilitation; Psychiatry; Nursing; Internal medicine","score_opus":0.11182651970124827,"score_gpt":0.3825397898921499,"score_spread":0.27071327019090163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493501087","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02544064,0.9164689,0.000014866852,0.011782232,0.0047302092,0.007443038,0.0005943108,0.00017860107,0.0333472],"genre_scores_gemma":[0.72366434,0.22972631,0.00005016796,0.028861947,0.00033368004,0.00032139482,0.0015279365,0.0002832208,0.015230989],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896077,0.006347475,0.002090195,0.00084006303,0.0007019388,0.00041265332],"domain_scores_gemma":[0.99637854,0.00025925736,0.0011644765,0.0010132468,0.0001169745,0.0010674935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031040527,0.00056356867,0.0029634316,0.0002246215,0.000032652624,0.000007947898,0.00037331533,0.0001397399,0.00019876676],"category_scores_gemma":[0.0039618663,0.00037025288,0.0011443993,0.00052573055,0.00009021499,0.00002342731,0.00019039058,0.0010283266,0.00023197196],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00502659,0.004324207,0.008415832,0.06291664,0.00053775794,0.0014264259,0.000032414955,0.00000831788,0.000006637744,0.00020918749,0.85163647,0.06545955],"study_design_scores_gemma":[0.0024821793,0.01086149,0.38128957,0.033239335,0.00076872326,0.000006787166,8.207301e-7,0.0000117231475,7.3347616e-7,0.00013324012,0.570908,0.00029738268],"about_ca_topic_score_codex":0.00002725741,"about_ca_topic_score_gemma":0.0000062646945,"teacher_disagreement_score":0.6982237,"about_ca_system_score_codex":0.000077411874,"about_ca_system_score_gemma":0.0003034469,"threshold_uncertainty_score":0.99987495},"labels":[],"label_agreement":null},{"id":"W2496454534","doi":"10.17925/enr.2008.03.01.14","title":"Rivastigmine in the Treatment of Alzheimer’s Disease and Parkinson’s Disease Dementia","year":2008,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Alzheimer Society","keywords":"Rivastigmine; Medicine; Dementia; Disease; Parkinson's disease; Donepezil; Psychiatry; Internal medicine","score_opus":0.10494822346310924,"score_gpt":0.3201595608090969,"score_spread":0.21521133734598769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496454534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7142503,0.28154844,0.0000015036093,0.0032972405,0.00001800492,0.00062039663,0.000018780864,0.000015499105,0.00022981086],"genre_scores_gemma":[0.6903467,0.29990518,0.000013329758,0.009571304,0.00007341968,0.000029348827,0.00002833209,0.000011418568,0.000020948406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982611,0.00065870286,0.00036197176,0.0003522737,0.00019925644,0.00016671544],"domain_scores_gemma":[0.999087,0.000110634675,0.00008194896,0.00038418142,0.00002930439,0.00030694774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013318118,0.00019480965,0.00037219148,0.000035638346,0.000057083907,0.00000554009,0.00009187056,0.000008578755,0.00006894188],"category_scores_gemma":[0.00026218194,0.000101552774,0.0001766285,0.00015226961,0.00016151465,0.000032346194,0.00003296202,0.00007657583,0.000023265462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015964197,0.0066441395,0.9104257,0.0012638088,0.00016705808,0.030024713,0.00020645808,0.000007379338,0.0003601208,0.00012716328,0.008647961,0.040529057],"study_design_scores_gemma":[0.0006819425,0.00067440805,0.85752654,0.00024694687,0.00077804906,0.0000541959,6.7700597e-7,0.000017812954,0.000011414724,0.00000477612,0.13992646,0.0000767846],"about_ca_topic_score_codex":0.0000010741629,"about_ca_topic_score_gemma":3.464739e-7,"teacher_disagreement_score":0.1312785,"about_ca_system_score_codex":0.0000029674986,"about_ca_system_score_gemma":0.000028239036,"threshold_uncertainty_score":0.4141202},"labels":[],"label_agreement":null},{"id":"W2498212039","doi":"10.17925/enr.2011.06.01.31","title":"Measuring Disability Progression with the Multiple Sclerosis Functional Composite","year":2011,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Expanded Disability Status Scale; Medicine; Physical medicine and rehabilitation; Multiple sclerosis; Physical therapy; Quality of life (healthcare); Psychiatry","score_opus":0.33925592390060133,"score_gpt":0.31407797776244883,"score_spread":0.025177946138152496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498212039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9180558,0.033940133,0.00039233346,0.019413676,0.0001189498,0.0039399182,0.000011430088,0.00047055772,0.023657212],"genre_scores_gemma":[0.98021173,0.014602582,0.000642986,0.0042291307,0.00011759183,0.000091036265,0.000007792522,0.000030515414,0.00006665034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970121,0.0011375917,0.0003250406,0.0005070684,0.00065142656,0.00036680014],"domain_scores_gemma":[0.9986064,0.00032781303,0.000112648595,0.0005877214,0.00015209956,0.00021335394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012805725,0.00023122145,0.00041404754,0.00001574474,0.00029546727,0.00001922282,0.00025554505,0.000023169958,0.00032778704],"category_scores_gemma":[0.0012344461,0.0000987874,0.0001743027,0.000260372,0.0006704254,0.0000622046,0.00035008552,0.00053348875,0.0002525068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020476137,0.0015058839,0.6328569,0.0020583044,0.0001621022,0.00020895312,0.00013371893,0.0000029603384,0.0058566714,0.00004120372,0.0077510946,0.34737456],"study_design_scores_gemma":[0.0006253566,0.0007627614,0.9683423,0.001371116,0.00009028003,0.000038642203,0.000003807032,0.000027378606,0.00012407375,0.0000012834901,0.028502826,0.00011019475],"about_ca_topic_score_codex":0.000003873304,"about_ca_topic_score_gemma":0.0000031204283,"teacher_disagreement_score":0.34726438,"about_ca_system_score_codex":0.00002022013,"about_ca_system_score_gemma":0.000013394942,"threshold_uncertainty_score":0.40284333},"labels":[],"label_agreement":null},{"id":"W2498961769","doi":"10.17925/enr.2011.06.03.170","title":"Stroke Rehabilitation - An Overview of Existing Guidelines and Standards of Care","year":2011,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rehabilitation; Medicine; Stroke (engine); Guideline; Best evidence; Health care; MEDLINE; Physical therapy; Intensive care medicine; Pathology","score_opus":0.25730854178400586,"score_gpt":0.422859742719189,"score_spread":0.16555120093518316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498961769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6266662,0.34302482,0.00006614759,0.00070115365,0.00011054774,0.00079701917,0.00006678239,0.000056975165,0.028510386],"genre_scores_gemma":[0.77755654,0.19749802,0.021589505,0.0031130381,0.000079459125,0.000009381871,0.000016805829,0.000039297032,0.000097930315],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979998,0.0005916394,0.0007198368,0.00024602635,0.0003409044,0.00010182254],"domain_scores_gemma":[0.99823475,0.00024619236,0.00023673801,0.00028973032,0.0008917557,0.00010085429],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0013754618,0.000117447875,0.00052970345,0.000051562314,0.00002054211,0.0000022075671,0.000077397184,0.000029110537,0.00017190569],"category_scores_gemma":[0.008445291,0.000077398494,0.00014492155,0.00012131043,0.00016922777,0.00005290064,0.000053537424,0.000111897316,0.0000032000912],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008844701,0.000594642,0.12933539,0.056338802,0.00007657293,0.00009077176,0.0019135283,0.0000027076424,0.0037887176,0.0052709486,0.0027874692,0.798916],"study_design_scores_gemma":[0.0010620387,0.017238423,0.75542855,0.009392697,0.00034998695,0.00006642547,0.00024883554,0.000026123436,0.00013292946,0.00012727926,0.21571456,0.00021215268],"about_ca_topic_score_codex":0.0000038081355,"about_ca_topic_score_gemma":7.724997e-7,"teacher_disagreement_score":0.79870385,"about_ca_system_score_codex":0.000009490824,"about_ca_system_score_gemma":0.000040030536,"threshold_uncertainty_score":0.999907},"labels":[],"label_agreement":null},{"id":"W2500149517","doi":"10.17925/enr.2014.09.01.19","title":"Effect of Therapeutic Interventions on Health-related Quality of Life in Parkinson’s Disease","year":2014,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"Teva Pharmaceutical Industries","keywords":"Medicine; Rasagiline; Entacapone; Parkinson's disease; Quality of life (healthcare); Clinical trial; Disease; Selegiline; Levodopa; Physical therapy; Internal medicine","score_opus":0.08007996613588365,"score_gpt":0.369704069017225,"score_spread":0.2896241028813414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500149517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90791124,0.085462734,0.000053829426,0.003358277,0.00007829249,0.0012777752,0.000021857308,0.000051049148,0.0017849444],"genre_scores_gemma":[0.98080224,0.014214652,0.000014198477,0.004865773,0.000011709989,0.00002221066,0.000021003083,0.000018269244,0.000029972076],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9933224,0.00497946,0.00095320534,0.00032761248,0.00023268691,0.00018468569],"domain_scores_gemma":[0.9984126,0.00039588427,0.00042199512,0.00042697697,0.000025732776,0.0003168246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023627165,0.00017862234,0.0009703299,0.0000634542,0.000022021286,0.0000024923895,0.00012445572,0.000022559529,0.00014987752],"category_scores_gemma":[0.0019742644,0.00011122987,0.0004876415,0.00019743759,0.000059721006,0.000015987796,0.00005003544,0.00018724792,0.00008523189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056431214,0.00578995,0.26465857,0.042351566,0.00026998261,0.0003324005,0.000027147542,0.000023652943,0.00012306041,0.0043823286,0.00065421796,0.675744],"study_design_scores_gemma":[0.0022066566,0.0063156104,0.97006106,0.0048797554,0.00018572265,0.00000246326,2.4862004e-7,0.00005058894,0.000009404412,0.00012569627,0.016080137,0.000082655504],"about_ca_topic_score_codex":0.000009104836,"about_ca_topic_score_gemma":0.0000010530011,"teacher_disagreement_score":0.7054025,"about_ca_system_score_codex":0.000013274057,"about_ca_system_score_gemma":0.000024260622,"threshold_uncertainty_score":0.45358223},"labels":[],"label_agreement":null},{"id":"W2780149296","doi":"10.17925/enr.2017.12.02.64","title":"Preventative Therapies for Migraine","year":2017,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Migraine; Intensive care medicine; Physical medicine and rehabilitation; Anesthesia","score_opus":0.12192867107125539,"score_gpt":0.4094433864359532,"score_spread":0.2875147153646978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780149296","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056205902,0.42608276,0.0004431694,0.2578764,0.00011497378,0.005178715,0.000042655007,0.00030189168,0.2537535],"genre_scores_gemma":[0.46498576,0.3924904,0.0033092059,0.10187663,0.0010190305,0.00018958024,0.000035252604,0.00008666668,0.03600747],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99897766,0.00017639749,0.00024626005,0.000282151,0.00011119888,0.00020634073],"domain_scores_gemma":[0.9990384,0.00013947075,0.00015932448,0.0004959365,0.00007688574,0.00008997151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005732557,0.00015226608,0.00045291838,0.000013397874,0.00029893056,0.000021633978,0.00021612529,0.000017380376,0.00016772111],"category_scores_gemma":[0.00249423,0.00008989577,0.00029856738,0.000025258378,0.00015966369,0.000039296305,0.000120792516,0.00015467225,0.00014227061],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036306237,0.0003848916,0.010227159,0.0049316315,0.00028263254,0.00045375086,0.00035543292,4.8308323e-8,0.0006019433,0.003370035,0.81625015,0.16277924],"study_design_scores_gemma":[0.000507125,0.0010296464,0.1619188,0.0005777103,0.00015331486,0.000031053558,0.0000045099027,0.000002575272,0.000008095547,0.00018007965,0.8355041,0.00008294084],"about_ca_topic_score_codex":0.0000012247651,"about_ca_topic_score_gemma":0.0000015720623,"teacher_disagreement_score":0.40877986,"about_ca_system_score_codex":0.000002834859,"about_ca_system_score_gemma":0.000009766315,"threshold_uncertainty_score":0.36658433},"labels":[],"label_agreement":null},{"id":"W2902148099","doi":"10.17925/enr.2018.13.2.103","title":"Management of Migraine and the Accessibility of Specialist Care – Findings from a Multi-national Assessment of 28 Healthcare Networks","year":2018,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"Novartis Pharma","keywords":"Migraine; Medicine; Referral; Triage; Specialty; Consistency (knowledge bases); Health care; Best practice; Delegation; Family medicine; Nursing; Medical emergency; Psychiatry","score_opus":0.07544529581554045,"score_gpt":0.3944507385794751,"score_spread":0.31900544276393467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902148099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6594343,0.28505188,0.00057417713,0.025056046,0.0000879248,0.0032985741,0.00015013995,0.000043129246,0.026303815],"genre_scores_gemma":[0.9390339,0.056819484,0.0012283647,0.0026834111,0.000110821835,0.0000076063707,0.00002226361,0.000008060359,0.000086043976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819577,0.0004950178,0.0006170859,0.0002685836,0.0003030916,0.00012044084],"domain_scores_gemma":[0.9988823,0.0002065445,0.000263883,0.00027163042,0.00032288968,0.00005274966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009997503,0.00012532623,0.0006316327,0.00001974383,0.000052978194,0.0000031485124,0.00015552831,0.000022727187,0.00010180947],"category_scores_gemma":[0.00032903266,0.00006736495,0.00016468282,0.00016358972,0.0005581022,0.000015736587,0.00026265119,0.00016691422,0.0000013817872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028877016,0.0020181555,0.7231276,0.059159234,0.0015144878,0.0003109524,0.0038855807,0.000007398782,0.00023297209,0.025780262,0.057808783,0.12326685],"study_design_scores_gemma":[0.0013337618,0.0005433934,0.9742775,0.0016054198,0.00022640762,0.0000028073566,0.000050093968,0.00014064906,0.000004341094,0.00004909372,0.021712676,0.00005385278],"about_ca_topic_score_codex":0.00003101379,"about_ca_topic_score_gemma":0.00001751119,"teacher_disagreement_score":0.27959964,"about_ca_system_score_codex":0.000009165185,"about_ca_system_score_gemma":0.000018705292,"threshold_uncertainty_score":0.27470627},"labels":[],"label_agreement":null},{"id":"W2962988692","doi":"10.17925/enr.2019.14.1.44","title":"Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy – Neurologist, Nursing and Patient Perspectives","year":2019,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Grifols; GBS/CIDP Foundation International; Argenx; Biogen; Union Chimique Belge; Sanofi; Alnylam Pharmaceuticals; Pfizer; CSL Behring; Myasthenia Gravis Foundation of America","keywords":"Chronic inflammatory demyelinating polyneuropathy; Medicine; Polyneuropathy; Physical medicine and rehabilitation; Antibody; Physical therapy; Immunology; Internal medicine","score_opus":0.010185562298052342,"score_gpt":0.2553008263591872,"score_spread":0.24511526406113487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962988692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82942295,0.15754129,0.0000033842305,0.0034021721,0.00013548815,0.0008909351,0.0000020635239,0.00013660996,0.008465125],"genre_scores_gemma":[0.91195005,0.076555856,0.000041680407,0.011257266,0.000059595175,0.000008876243,0.0000030556562,0.00005637245,0.0000672443],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99666804,0.0010119549,0.0006503058,0.0008192832,0.00027783212,0.00057258666],"domain_scores_gemma":[0.99895686,0.00015706087,0.00019686807,0.0004579096,0.00005449423,0.00017678752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038700554,0.0003557491,0.00063176133,0.000087189954,0.00007606608,0.000030263995,0.00019102526,0.000059822036,0.00017228916],"category_scores_gemma":[0.00072620594,0.00027743206,0.00016753837,0.00028841614,0.00022974359,0.00008650075,0.00019702679,0.0008729827,0.00016875617],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024188242,0.0012788414,0.06480874,0.00471881,0.000049580765,0.029012538,0.0012828695,0.00032179532,0.018666802,0.0016066591,0.0020358104,0.8737987],"study_design_scores_gemma":[0.0056714267,0.030177277,0.7082362,0.008873991,0.00024093564,0.0092808,0.00050825946,0.0030095621,0.000030968422,0.00024112078,0.23194778,0.0017816332],"about_ca_topic_score_codex":0.0000032175744,"about_ca_topic_score_gemma":0.0000016812065,"teacher_disagreement_score":0.8720171,"about_ca_system_score_codex":0.000067405206,"about_ca_system_score_gemma":0.000059912487,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W3005819287","doi":"10.17925/enr.2019.14.2.73","title":"Ozanimod in Multiple Sclerosis","year":2019,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation","funders":"Juno Therapeutics; Ontario Institute for Regenerative Medicine; Hospital for Sick Children; Multiple Sclerosis Society; Alexion Pharmaceuticals; F. Hoffmann-La Roche; Stem Cell Network; Biogen; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Physical medicine and rehabilitation; Psychiatry","score_opus":0.043578448185137245,"score_gpt":0.2380263955032357,"score_spread":0.19444794731809845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005819287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94364285,0.04801576,0.000039354883,0.00029467428,0.00015679307,0.00032298462,0.000003108943,0.000021091595,0.0075034066],"genre_scores_gemma":[0.9453656,0.043837864,0.00013636211,0.010263514,0.00014601513,0.0000069375906,0.000020438454,0.000023916597,0.00019933433],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985374,0.00042487256,0.00027412723,0.00042383754,0.000102000515,0.0002377141],"domain_scores_gemma":[0.99944514,0.000026485432,0.00006426729,0.0003710368,0.00002082057,0.00007226958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058590295,0.00014288595,0.00024188569,0.000021312397,0.000022761024,0.000012753048,0.00028370746,0.000041171184,0.0001467904],"category_scores_gemma":[0.0004824785,0.00011025561,0.00011911803,0.000121613106,0.00002732672,0.000003017623,0.00018666449,0.00015301039,0.0005541209],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018081543,0.0002779291,0.09606967,0.0007343248,0.000022850205,0.000090804686,0.000018431947,0.00012811713,0.83348435,0.0003239311,0.006710234,0.061958518],"study_design_scores_gemma":[0.0010169728,0.00041574368,0.20378472,0.00045797013,0.000019520703,0.000020400807,0.0000018988998,0.00006400544,0.002342664,0.000012548262,0.7915365,0.00032707135],"about_ca_topic_score_codex":0.0000016298208,"about_ca_topic_score_gemma":0.0000010350528,"teacher_disagreement_score":0.8311417,"about_ca_system_score_codex":0.000001615087,"about_ca_system_score_gemma":0.0000086810105,"threshold_uncertainty_score":0.71222883},"labels":[],"label_agreement":null}]}